Global Small Animals Respiratory Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431627
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Animal Health
  • Cipla Vet
  • Heska Corporation
  • Merck Animal Health
  • MORE
Small Animals Respiratory Diseases Treatment Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2024, the small animals respiratory diseases treatment market was valued at USD 19,267.7 Mn in 2017, and is expected to reach USD 28,830 Mn by 2025, expanding at a CAGR of 2.5% from 2017 to 2025.

Market Insights

According to veterinary health experts, symptoms and diseases related with respiratory infection are frequent during the first of year life in small animals. These respiratory infections are usually caused by bacteria and virus transferred through an environmental media. The Banfield Pet Hospital suggested that in the U.S obesity in pets is increasing swiftly these days around 37% of dogs analyzed were overweight and around 90% of cats analyzed were obese. Thus, obesity is one of the prominent causes of respiratory diseases and other chronic disorders in small animals.

The market segmentation of small animal respiratory diseases treatment comprises type of diseases and drug class. According to market experts, allergic pneumonitis, canine influenza, rhinitis and sinusitis and tonsillitis were observed as the most common respiratory diseases observed in small animals. The most common symptoms observed in small animals such as coughing or dyspnoea with common disorders such as brachycephalic syndrome, laryngeal paralysis, tracheal collapse, and feline asthma syndrome According to American Veterinary Medical Foundation, the first recognized U.S. outbreak of H3N2 canine influenza occurred in 2015, starting in Chicago and spreading to other Midwestern states. Since March 2015, outbreaks have occurred in a number of areas throughout the U.S. and thousands of dogs have been confirmed positive for the H3N2 virus. It was observed that prevalence of canine influenza was also observed in cats and the displayed signs of upper respiratory disease including discharge, congestion, malaise, lip smacking and excessive salivation. In 2015, it was observed that anthelmintics, corticosteroids and antibiotics accounted for more than 50% market share of the overall small animal respiratory diseases treatment market. According to market experts, most anthelmintics have wide safety margins, i.e., the dosage that can be given to an animal before adverse effects are induced is much higher than the dosage recommended for use.

North America was observed as the largest market for small animal respiratory diseases treatment market due to factors such as rising air pollution, lack of sanitation related to pets in a few households, increasing urban trend of having dogs and cats as pets and rising awareness associated with the well-being of small animals.

Key Market Movements:
  • Rising air pollution accompanied with increasing obesity issues in pets
  • Lack of sanitization associated with pets and increasing urban trend of having dogs and cats as pets
  • There is a noticeable inclination towards pet humanization, especially among young, urban and affluent consumers, and is expected to trade up to mid-priced or premium products
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Animal Health
  • Cipla Vet
  • Heska Corporation
  • Merck Animal Health
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Small Animal Respiratory Diseases Treatment Market, by Type of Diseases, 2015 - 2025 (Value %)
2.2 Global Small Animal Respiratory Diseases Treatment Market, by Type of Drug Class, 2015 (USD Mn)
2.3 Global Small Animal Respiratory Diseases Treatment Market, by Geography, 2015 (Value %)

Chapter 3 Global Small Animal Respiratory Diseases Treatment Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising air pollution coupled with increasing obesity issues in pets
3.2.2 Lack of sanitization associated with pet shelter, pet stores and some households
3.2.3 Lack of sanitization associated with pet shelter, pet stores and some households
3.2.4 Increasing urban trend of having dogs and cats as pets accompanied with pet humanization
3.3 Market Restraints
3.3.1 Lack of public awareness associated with the veterinary respiratory disease symptoms and treatment
3.4 Market Opportunities
3.4.1 Small animal healthcare market growing significantly in Asia-Pacific and Middle East
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Small Animal Respiratory Diseases Treatment, by Key Players

Chapter 4 Global Small Animal Respiratory Diseases Treatment Market, By Type of Diseases
4.1 Overview
4.2 Allergic Pneumonitis
4.3 Canine Influenza
4.4 Canine Nasal Mites
4.5 Lung Nematodes
4.6 Neoplasia Of Respiratory System
4.7 Pneumonia
4.8 Rhinitis And Sinusitis
4.9 Tonsilitis
4.10 Other Respiratory Diseases (Tracheobronchitis, Lung Flukes, Pulmonary Thromboembolism, and Feline Respiratory Disease Complex)

Chapter 5 Global Small Animal Respiratory Diseases Treatment Market, By Type of Drug Class
5.1 Overview
5.2 Anthelmintics
5.3 Non-steroidal anti-inflammatory drugs (NSAIDs)
5.4 Corticosteroids
5.5 Antibiotics
5.6 Antihistamines
5.7 Phosphodiesterase (PDE) inhibitors
5.8 Bronchodilators
5.9 Antineoplastic Agents
5.10 Others (Beta Adrenergic Receptor Agonists, Anticoagulants, Antitussives and Immunosuppressants)

Chapter 6 Global Small Animal Respiratory Diseases Treatment Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.3 Europe (U.K, Germany and Rest of Europe)
6.4 Asia Pacific (China, Japan and Rest of Asia-Pacific)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Zoetis, Inc.
7.1.1 Zoetis, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Merck Animal Health
7.2.1 Merck Animal Health: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 Merial Inc. (Sanofi S.A)
7.3.1 Merial Inc. (Sanofi S.A): Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Elanco Animal Health (Eli Lilly)
7.5.1 Elanco Animal Health (Eli Lilly): Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.6 Bayer AG
7.6.1 Bayer AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.7 Ceva Animal Health
7.7.1 Ceva Animal Health: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.8 Heska Corporation
7.8.1 Heska Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.9 Vetoquinol SA
7.9.1 Vetoquinol SA: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.10 Virbac Ltd.
7.10.1 Virbac Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.11 Cipla Vet
7.11.1 Cipla Vet: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)

List of Figures
Fig. 1 Small Animal Respiratory Diseases Treatment Market: Research Methodology
Fig. 2 Global Small Animal Respiratory Diseases Treatment Market, by Type of Diseases, 2015 v/s 2024 (Value %)
Fig. 3 Global Small Animal Respiratory Diseases Treatment Market, by Type of Drug Class, 2015 (USD Mn)
Fig. 4 Global Small Animal Respiratory Diseases Treatment Market, by Geography, 2015 (Value %)
Fig. 5 Attractive Investment Proposition, by Geography, 2015
Fig. 6 Global Allergic Pneumonitis Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 7 Global Canine Influenza Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 8 Global Canine Nasal Mites Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 9 Global Lung Nematodes Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 10 Global Neoplasia Of Respiratory System Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 11 Global Pneumonia Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 12 Global Rhinitis And Sinusitis Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 13 Global Tonsilitis Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 14 Global Other Respiratory Diseases Treatment Market in Small Animals, 2015 - 2025 (USD Mn)
Fig. 15 Anthelmintics Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 16 NSAIDs Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 17 Corticosteroids Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 18 Antibiotics Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 19 Antihistamines Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 20 Phosphodiesterase (PDE) inhibitors Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 21 Bronchodilators Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 22 Antineoplastic Agents Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 23 Other Drug Classes Market for Small Animal Respiratory Diseases Treatment, 2015 - 2025 (USD Mn)
Fig. 24 North America Small Animal Respiratory Diseases Treatment Market, By Country, 2015 - 2025 (USD Mn)
Fig. 25 Europe Small Animal Respiratory Diseases Treatment Market, By Country, 2015 - 2025 (USD Mn)
Fig. 26 Asia-Pacific Small Animal Respiratory Diseases Treatment Market, By Country, 2015 - 2025 (USD Mn)
Fig. 27 Latin America Small Animal Respiratory Diseases Treatment Market, By Country, 2015 - 2025 (USD Mn)
Fig. 28 Middle East and Africa Small Animal Respiratory Diseases Treatment Market, 2015 - 2025 (USD Mn)

List of Tables
Table 1 Market Competition Assessment: Precision Medicine, by Key Players
Table 2 Global Small Animal Respiratory Diseases Treatment Market, by Type of Diseases, 2015 - 2025 (USD Mn)
Table 3 Global Small Animal Respiratory Diseases Treatment Market, By Type of Drug Class, 2014-2024 (USD Mn)
Table 4 Global Small Animal Respiratory Diseases Treatment Market, by Geography, 2015 - 2025 (USD Mn)
Table 5 Zoetis, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 6 Merck Animal Health: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 7 Merial Inc. (Sanofi S.A): Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 8 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 9 Elanco Animal Health (Eli Lilly): Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 10 Bayer AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 11 Ceva Animal Health: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 12 Heska Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 13 Vetoquinol SA: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 14 Virbac Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 15 Cipla Vet: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Zoetis, Inc.
  • Merck Animal Health
  • Merial Inc. (Sanofi S.A)
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health (Eli Lilly)
  • Bayer AG
  • Ceva Animal Health
  • Heska Corporation
  • Vetoquinol SA
  • Virbac Ltd.
  • Cipla Vet
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll